Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-17
2011-05-17
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S082000
Reexamination Certificate
active
07943635
ABSTRACT:
This invention comprises the novel compounds of formula (I)wherein r, t, Y1, Y2, R1, R2, R3, R5, R6and R7have defined meanings, having farnesyl transferase inhibiting activity; their preparation, compositions containing them and their use as a medicine.
REFERENCES:
patent: 4061754 (1977-12-01), Black
patent: 4468400 (1984-08-01), Gold et al.
patent: 4738967 (1988-04-01), Ueda et al.
patent: 5968952 (1999-10-01), Venet et al.
patent: 6037350 (2000-03-01), Venet et al.
patent: 6458800 (2002-10-01), Angibaud et al.
patent: 7569580 (2009-08-01), Thota et al.
patent: WO 97/16443 (1997-05-01), None
patent: WO 97/21701 (1997-06-01), None
patent: WO 97/36876 (1997-10-01), None
patent: WO 98/40383 (1998-09-01), None
patent: WO 98/49157 (1998-10-01), None
patent: WO 98/55124 (1998-12-01), None
patent: WO 00/01386 (2000-01-01), None
patent: WO 00/01411 (2000-01-01), None
patent: WO 00/12498 (2000-03-01), None
patent: WO 00/12499 (2000-03-01), None
patent: WO 00/39082 (2000-07-01), None
patent: WO 00/47574 (2000-08-01), None
patent: WO 01/53289 (2001-07-01), None
patent: WO 02/24686 (2002-03-01), None
patent: WO 02/24687 (2002-03-01), None
Kohl et al., “Selective Inhibition ofras-Dependent Transformation by a Famesyltransferase Inhibitor”, Science, (1993), vol. 260, No. 5116, pp. 1934-1937.
Rak et al., “MutantrasOncogenes Upregulate VEGF/VPF Expression: Implications for Induction and Inhibition of Tumor Angiogenesis”, Cancer Research, (1995), vol. 55, No. 20, pp. 4575-4580.
International Search Report PCT/EP2003/02874, mailed Jul. 24, 2003.
Angibaud Patrick Rene
Breslin Henry Joseph
Meyer Christophe
Venet Marc Gaston
Janssen Pharmaceutica NV
Truong Tamthom N
Wilson James O
LandOfFree
Benzylimidazolyl substituted 2-quinoline and quinazoline... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzylimidazolyl substituted 2-quinoline and quinazoline..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzylimidazolyl substituted 2-quinoline and quinazoline... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2651867